China approves first antibody Covid treatment.
Wednesday, December 8th, 2021Courtesy RT China’s medical regulator has approved Brii Biosciences’ antibody combination Covid-19 treatment for adults and adolescents, making it the first therapy of this kind given the green light in the country. The BRII-196/BRII-198 combination is intended to treat mild Covid-19 and common types” of the disease in patients with high risk of developing severe […]
More >